Related Experiment Video
Updated: Oct 3, 2025

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus MRSA
Published on: February 9, 2011
Severe Skin and Soft-Tissue Infections.
Addison E Stieferman1, Patrick Mazi2, Jason P Burnham2
1Department of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri.
Severe skin and soft-tissue infections (SSTIs) require prompt source control and antimicrobials. Management is complex, influenced by pathogens, resistance, and host factors, with ongoing research into therapies like IV immunoglobulin.
Area of Science:
- Infectious Diseases
- Critical Care Medicine
- Microbiology
Background:
- Skin and soft-tissue infections (SSTIs) are frequent causes of hospitalization, with severe cases often necessitating intensive care.
- Necrotizing infections represent a critical subset of SSTIs demanding urgent intervention.
- Effective management hinges on source control and appropriate antimicrobial selection.
Purpose of the Study:
- To review current strategies for managing severe skin and soft-tissue infections (SSTIs).
- To discuss the role of source control, antimicrobial therapy, and adjunctive treatments.
- To highlight the impact of host factors and regional variations on clinical outcomes.
Main Methods:
- Literature review focusing on severe SSTIs, necrotizing infections, and management principles.
- Analysis of data regarding source control, antimicrobial agents, and novel therapeutic options.
- Examination of host-related factors influencing disease progression and treatment response.
Main Results:
- Early source control (surgical debridement) and effective antimicrobial therapy are crucial for reducing morbidity and mortality.
- Rapid diagnostic tests can aid in antimicrobial selection and de-escalation.
- Intravenous immunoglobulin and hyperbaric oxygen therapy are explored as adjuncts, though challenges in trial recruitment persist.
Conclusions:
- Severe SSTIs are complex, multifactorial conditions requiring a comprehensive management approach.
- Host immune status and pathogen-specific characteristics significantly influence outcomes.
- Continued research is needed to optimize treatment strategies and address antimicrobial resistance.
Related Concept Videos
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Acute Pyelonephritis II: Diagnostic Studies and Management
Burn Injuries
The damage results in the death of skin cells, which can lead to a massive loss of fluid. Dehydration, electrolyte imbalance, and renal and circulatory failure follow, which can be fatal. Burn patients are treated with intravenous fluids to offset...
Endocarditis I: Introduction
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
Endocarditis IV: Nursing Management

